Meeting
2018 ASCO Annual Meeting
Risk of second malignancies in breast cancer patients who received chemotherapy: A SEER analysis.
Authors
Snigdha Nutalapati
Morehouse School of Medicine, Atlanta, GA
Snigdha Nutalapati , Sanjay R. Jain
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1565)
DOI
10.1200/JCO.2018.36.15_suppl.1565
Abstract #
1565
Poster Bd #
136
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Ki-67 level in hormone reptor positive breast cancer patients: A retrospective review of 9,061 Korean women.
First Author: Jisun Kim
Poster
2023 ASCO Quality Care Symposium
Disparities in time to initiation of treatment among patients with metastatic solid tumors in Washington state.
First Author: Catherine R. Fedorenko
Poster
2023 ASCO Annual Meeting
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.
First Author: Esther G Chong
Poster
2021 ASCO Quality Care Symposium
Fertility preservation in young breast cancer patients: A population-based study.
First Author: Diana Nguyen